INT171641

Context Info Confidence 0.03 First Reported 2002 Last Reported 2002 Negated 0 Speculated 0 Reported most in Body Documents 1 Total Number 5 Disease Relevance 0.86 Pain Relevance 0.26

cytosol (TAB3) plasma membrane (TAB3) intracellular (TAB3)

Anatomy Link Frequency leukocyte 6 platelet 2 TAB3 (Homo sapiens)

Pain Link Frequency Relevance Heat ischemia 70 81.04 anesthesia 5 64.88 Kinase C 15 5.00 aspirin 5 5.00 cytokine 5 5.00 Inflammation 5 5.00 Inflammatory marker 5 5.00 imagery 5 5.00 antagonist 5 5.00

Disease Link Frequency Relevance Heat Adhesions 105 95.76 Cv Unclassified Under Development 70 81.04 Increased Venous Pressure Under Development 25 41.28 Injury 75 16.92 Pressure And Volume Under Development 5 5.56 Stress 25 5.00 Myocardial Infarction 25 5.00 Thrombosis 15 5.00 INFLAMMATION 10 5.00 Coronary Artery Disease 10 5.00

Sentences Mentioned In

Key:

Protein

Mutation

Event

Anatomy

Negation

Speculation

Pain term

Disease term

In AB and EF groups a slight increase in permeability was observed from 20–30 min after reperfusion when compared with tEF and tAB groups (tAB -25% and tEF: -57% vs. the ABI and EF groups, respectively, p < 0.05) Changes in platelet and leukocyte adhesion on microvessels

Negative_regulation (reperfusion) of Gene_expression (groups) of tAB in leukocyte associated with adhesions

1) Confidence 0.03 Published 2002 Journal BMC Cardiovasc Disord Section Body Doc Link PMC117121 Disease Relevance 0.18 Pain Relevance 0.04

In AB and EF groups a slight increase in permeability was observed from 20–30 min after reperfusion when compared with tEF and tAB groups (tAB -25% and tEF: -57% vs. the ABI and EF groups, respectively, p < 0.05) Changes in platelet and leukocyte adhesion on microvessels

Negative_regulation (reperfusion) of Gene_expression (groups) of tAB in leukocyte associated with adhesions

2) Confidence 0.03 Published 2002 Journal BMC Cardiovasc Disord Section Body Doc Link PMC117121 Disease Relevance 0.17 Pain Relevance 0.04

g/100 g infused intravenously); the fifth group (tAB, n = 6) was treated with t-PA plus abciximab (50 plus 0.6 ?

Negative_regulation (treated) of Gene_expression (group) of tAB

3) Confidence 0.03 Published 2002 Journal BMC Cardiovasc Disord Section Body Doc Link PMC117121 Disease Relevance 0.16 Pain Relevance 0.11

In AB and EF groups a slight increase in permeability was observed from 20–30 min after reperfusion when compared with tEF and tAB groups (tAB -25% and tEF: -57% vs. the ABI and EF groups, respectively, p < 0.05) Changes in platelet and leukocyte adhesion on microvessels

Negative_regulation (reperfusion) of in platelet Gene_expression (groups) of tAB in leukocyte associated with adhesions

4) Confidence 0.01 Published 2002 Journal BMC Cardiovasc Disord Section Body Doc Link PMC117121 Disease Relevance 0.18 Pain Relevance 0.04

In AB and EF groups a slight increase in permeability was observed from 20–30 min after reperfusion when compared with tEF and tAB groups (tAB -25% and tEF: -57% vs. the ABI and EF groups, respectively, p < 0.05) Changes in platelet and leukocyte adhesion on microvessels

Negative_regulation (reperfusion) of in platelet Gene_expression (groups) of tAB in leukocyte associated with adhesions

5) Confidence 0.01 Published 2002 Journal BMC Cardiovasc Disord Section Body Doc Link PMC117121 Disease Relevance 0.17 Pain Relevance 0.04

General Comments

This test has worked.